APTCF Stock UPDATES Advanced Proteome Th (APTCF) 0.2700 09/16/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Advanced Proteome Th (APTCF) 0.2700 $APTCF

APC Announces Positive Results in Combination Cancer Immunotherapy
Marketwire - Thu Sep 11, 8:02AM CDT
Advanced Proteome Therapeutics Corporation ("APC" or the "Company" (TSX VENTURE: APC) (FRANKFURT: 0E8) is excited to report results from its current round of experiments that not only reinforce previous evidence of the immunotherapeutic properties of APC's protein modification technology, but hold forth the possibility of synergistic effects with other immunotherapies while heralding the entry of a new and potentially powerful approach in the arsenal of anticancer weaponry.

Advanced Proteome Therapeutics Expands Anticancer Studies Base D on Strong Initial Results
Marketwire - Tue Aug 12, 8:28AM CDT
Advanced Proteome Therapeutics Corporation ("APC" or the "Company" (TSX VENTURE: APC)(FRANKFURT: 0E8) is pleased to announce that it has expanded and accelerated its anticancer studies to strengthen their commercial prospects because recent positive results with collaborators have demonstrated that modifications of APC's protein delivery system substantially increases antitumor activity and retards tumor growth in animals.

Advanced Proteome Therapeutics Reports Impressive Anticancer Activity
Marketwire - Wed Mar 05, 1:10PM CST
Advanced Proteome Therapeutics Corporation ("APC" or the "Company" (TSX VENTURE: APC) has been preparing several series of potential anticancer agents, each of which has its own individual attributes for drug development as novel proprietary agents.

Yale prepares for atom smasher's farewell, sets stage for new physics era
M2 - Tue Feb 25, 8:45AM CST


Frost & Sullivan: Medical Robots Will Revolutionize Most Surgical Disciplines
M2 - Tue Feb 25, 6:34AM CST
Surgical robots are gaining widespread acceptance across the globe as they enhance the surgeons abilities in terms of surgical imaging, navigation, planning and instrument manipulation. Market participants are conducting extensive research in this field to further strengthen the capabilities of surgeons through advanced imaging techniques, higher degrees of freedom, interactive interfaces, haptics feedback, and teleoperation. Surgical robot manufacturers are also trying to reduce the footprint of existing robotic systems and lessen the invasiveness of surgical procedures by advancing single port, natural orifice, and swarm robotic technologies.

Advanced Proteome Therapeutics Corp. (APC) Provides Update on Ongoing Activities
Marketwire - Thu Dec 19, 1:07PM CST
Advanced Proteome Therapeutics Corporation ("APC" or the "Company" (TSX VENTURE: APC) is pleased to announce that through calendar year 2013 the Company has been applying its enabling Foundation Trinity(TM) Technology to proteins targeted for the treatment of cancers. Advanced, targeted therapies are intended to attack primarily cancer cells and are expected to dominate the anti-cancer therapeutics market in the near future. APC's technology will enable not only therapy targeted for tumor cells, but also the delivery of combination therapy in a single, pure therapeutic agent. To achieve this, it has been the Company's intention to utilize a unique protein, not only as a delivery system to tumor cells, but also as a scaffold upon which to attach each anti-cancer entity to its own specific site on the protein surface - both key to efficient manufacturing and product development. What is more, the protein itself appears to possess immunotherapeutic properties. Immunotherapy is perhaps the most powerful current approach to cancer, and one of great commercial interest to the pharmaceutical industry. This vision, the unique nature of the protein, and the ability to apply its proprietary enabling chemical technology to modification of the protein, differentiate APC from the competition.

Advanced Proteome Therapeutics Announces Agreement With Stanford University School of Medicine for Testing of Foundation Trinity(TM) Technology
Marketwire - Mon May 13, 7:43AM CDT
Advanced Proteome Therapeutics Corporation ("APC" or the "Company" (TSX VENTURE: APC) is pleased to announce that it has executed an agreement with the Stanford University School of Medicine, Department of Radiology, to test protein conjugates and multimers as part of APC's "Foundation Trinity(TM)" technology involving targeted, combination, and homogeneous therapy in a single anti-cancer agent. Stanford will be testing APC's protein modifications to determine their effects on tumors in a variety of cancer disease states.

Advanced Proteome Announces Agreement With The University of Iowa for Testing of Foundation Trinity(TM) Technology
Marketwire - Mon Apr 29, 7:40AM CDT
Advanced Proteome Therapeutics Corporation ("APC" or the "Company" (TSX VENTURE: APC) is pleased to announce that it has executed an agreement with The University of Iowa on behalf of Dr. Joel Shilyansky for the testing of protein conjugates and multimers as part of APC's "Foundation Trinity(TM)" technology. Dr. Shilyansky holds the Robert and Helene Soper Chair of Pediatric Surgery at the University of Iowa Carver College of Medicine. Dr. Shilyansky will be performing the testing of APC's protein modifications in the University of Iowa laboratories to determine their effects on tumor growth and immunogenicity. A focal point of his interest is the protection from tumor challenge, afforded by proteins with high affinity for cancers cells, through immune-mediated mechanisms.

Advanced Proteome Therapeutics Corporation Prepares Proprietary Protein Conjugates to Be Tested for Anti-Cancer Activities
Marketwire - Thu Mar 14, 10:30AM CDT
Advanced Proteome Therapeutics Corporation ("APC" or the "Company" (TSX VENTURE: APC) announced today that it has achieved the preparation of certain novel, proprietary protein conjugates and multimers that the Company has designed for testing as anticancer agents. (A protein conjugate is a protein that is linked to a non-protein. A multimer is a substance in which more than one protein is linked together.) Using APC technologies, the Company has applied synthetic methods that are site-specific and thus permit the production of homogeneous products, which represent the gold standard of purity in the industry.

Break Out Stocks - Stocks Touching 52 Week Highs/Lows on Two Consecutive Days (NYSE: SRT) (TSXV: APC)
ACCESSWIRE-TNW - Thu Feb 28, 8:37AM CST
Toronto, Canada: : In tracking the small cap stock universe of US and Canadian stocks for Wednesday, February 27, 2013, Ubika Research based on the proprietary criteria found that the following companies touched 52 week highs or lows for 2 consecutive days during the trading session: StarTek Inc. (NYSE: SRT), Advanced Proteome Therapeutics Corp. (TSX VENTURE: APC) (CVE: APC) among others.

Ubika Research's Daily Canadian Box Score: Top Junior Diversified Mining (CNSX: XBR) Stock Gained 25%
ACCESSWIRE-TNW - Thu Feb 28, 8:32AM CST
TORONTO, Canada: In tracking the small cap stock universe of Canadian stocks based on proprietary criteria for Wednesday, February 27, 2013, Ubika Research found the top small cap stock gainers from each of the following sectors.

Advanced Proteome Therapeutics Corp. (APC) Announces New Directions in Cancer Therapies
Marketwire - Mon Feb 25, 7:27AM CST
Preparation and testing of innovative, homogeneous drugs: combining multiple therapies by linking them to a protein which is directly targeted to cancer tumors and has been shown to promote anti-tumor immunity. The Advanced Protein Conjugate Therapeutic (APCT).




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 0

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 24

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 117

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 20

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 231

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 0

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading

Top 5 Most Recently Viewed Articles

T. Rowe Price OHA Credit Fund Reports Strong Q2 Performance

Updated Category News Views 146

Financial Performance Overview T. Rowe Price OHA Select Private Credit Fund (NASDAQ: OCREDIT) recently reported its financial results for the quarter ended June 30, 2025. The fund declared total distributions amounting to $0.81 per share for this period. This reflects the growing significance of private credit as a financing solution in today's credit markets. Investment...

Continue Reading
Toll Brothers Unveils Luxurious Townhome Community in Armonk

Updated Category News Views 222

Discover the Enclave at Armonk Located in Armonk, the newly launched Enclave at Armonk invites homebuyers to experience luxury living blended with convenience. This new community by Toll Brothers represents a significant addition to the Westchester County real estate market, bringing elegant townhome designs that promise sophistication and comfort. A Closer Look at the...

Continue Reading
XAI Octagon Trust Expands Opportunities with New Preferred Shares

Updated Category News Views 108

XAI Octagon Trust Issues Convertible Preferred Shares XAI Octagon Floating Rate & Alternative Income Trust (NYSE:XFLT), a diversified closed-end management investment company, has made a significant move by announcing the issuance and sale of 400,000 shares of its 6.95% Series II 2029 Convertible Preferred Shares. This initiative enhances the Trust's capital resources and...

Continue Reading
Endeavour Mining's Recent Share Buyback Activity Overview

Updated Category News Views 208

Endeavour Mining Announces Recent Share Buyback In a significant move for shareholders, Endeavour Mining plc (LSE: EDV, TSX: EDV) has disclosed its recent buyback of ordinary shares. These transactions showcase the company's ongoing commitment to enhancing shareholder value and demonstrate a strategic approach to managing its equity. Details of the Share Buyback Endeavour...

Continue Reading
Sleep Awareness Week 2025: Importance of Quality Sleep

Updated Category News Views 459

National Sleep Foundation Announces 2025 Dates for Sleep Awareness Week Today, the National Sleep Foundation (NSF) has shared that Sleep Awareness Week in 2025 will be observed from March 9 to March 15. This annual campaign aims to highlight the critical role sleep plays in promoting health and overall well-being, encouraging the public to prioritize high-quality sleep....

Continue Reading